Position in MEDP
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$481,926
+$171,244 QoQ
Shares Held
910
+40.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#409
of 691 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,469,091 across 9 Diagnostics & Research names. MEDP ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
5,353 | $941,217 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,412 | $707,920 | |
| 3 | NTRA |
Natera, Inc.
|
2,272 | $616,734 | |
| 4 | MEDP |
Medpace Holdings, Inc.
This page
|
910 | $481,926 | |
| 5 | DHR |
Danaher Corp /De/
|
2,381 | $453,532 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
728 | $383,248 | |
| 7 | A |
Agilent Technologies, Inc.
|
2,854 | $379,096 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,566 | $302,582 |
All Filings in MEDP
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $481,926 | 910 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $310,682 | 647 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $363,387 | 647 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $332,661 | 647 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $235,081 | 749 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $236,744 | 777 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $242,527 | 730 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $233,993 | 701 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $315,888 | 767 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $307,154 | 760 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $225,606 | 736 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||